Nextech, a Swiss biotech investment firm focused on cancer treatments, is reportedly preparing to begin talks with corporations to be LPs in its next fund.
Alfred Scheidegger (pictured), founding partner of Nextech, said it could essentially act as the “outsourced” venture arm of a corporation, according to news provider Private Equity News (disclosure: I used to edit the magazine title).
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
